Inborn Errors of Ketogenesis: Novel Variants, Clinical Presentation, and Follow-Up in a Series of Four Patients

 

 Buy Article Permissions and Reprints

Abstract

Inborn errors of ketogenesis are rare disorders that result in acute and fulminant decompensation during lipolytic stress, particularly in infants and children. These include mitochondrial 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase (HMGCS) deficiency and HMG-CoA lyase (HMGCL) deficiency. In this series, we describe the clinical, biochemical, and molecular profiles of four patients along with dietary interventions and their outcomes on a long-term follow-up. Two patients each of HMGCS and HMGCL deficiency were evaluated with clinical history, biochemical investigations, including tandem mass spectrometry (TMS) and urine gas chromatography-mass spectrometry (GCMS). Molecular analysis was performed by whole-exome sequencing, as well as exon array validated by long-range polymerase chain reaction. All individuals were diagnosed with acute metabolic decompensation in the early infancy period except one with HMGCL deficiency who had the first presentation at 5 years of age. Central nervous system manifestations, severe metabolic acidosis, hyperammonemia, hypoglycemia with a normal lactate, and absence of urinary ketones were observed in all the affected individuals. The disorder was life-threatening in three individuals and one succumbed to the illness. TMS was nonspecific and urine GCMS revealed dicarboxylic aciduria in HMGCS deficiency. Both the patients with HMGCL deficiency demonstrated elevated 3 hydroxyisovaleryl carnitine levels in TMS and metabolites of leucine degradation in urine GCMS. We identified five novel variants that included a large deletion involving exon 2 in HMGCL gene. There was no evidence of long-term neurological sequelae in the living individuals. Diet with moderation of fat intake was followed in two individuals with HMGCS deficiency. Low leucine and protein diet with moderation of fat intake was followed in the individual with HMGCL deficiency. All affected individuals are thriving well with no further major metabolic decompensation.

Authors' Contributions

H.S. contributed to data curation and writing original draft; S.S. to methodology and investigation; S.K. and B.V. to resources; S.K. to formal analysis and investigation; M.V. to exon array analysis and validation; P.C. to long range PCR validation and analysis; M.P. to software-based protein modeling and validation, A.M. to conceptualization and writing—reviewing and editing; and K.M. to conceptualization and writing—reviewing and editing and supervision.

Publication History

Received: 17 September 2021

Accepted: 24 March 2022

Article published online:
12 July 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Mitchell GA, Fukao T. Inborn errors of ketone body catabolism. In: Scriver CR, Beaudet al, Sly WS, Valle D. eds. Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York, NY: McGraw-Hill; 2001: 2327-2356
  Google Scholar
• 2 Sass JO, Fukao T, Mitchell GA. Inborn errors of ketone body metabolism and transport: an update for the clinic and for clinical laboratories. J Inborn Errors Metab Screen 2018; 6 DOI: 10.1177/2326409818771101.
  CrossrefPubMedGoogle Scholar
• 3 Bouchard L, Robert MF, Vinarov D. et al. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: clinical course and description of causal mutations in two patients. Pediatr Res 2001; 49 (03) 326-331
  CrossrefPubMedGoogle Scholar
• 4 Lin WD, Wang CH, Lai CC. et al. Molecular analysis of Taiwanese patients with 3-hydroxy-3-methylglutaryl CoA lyase deficiency. Clin Chim Acta 2009; 401 (1-2): 33-36
  CrossrefPubMedGoogle Scholar
• 5 Zhang P, Hu X, Guo R. et al. Novel HMGCS2 pathogenic variants in a Chinese family with mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency. Pediatr Investig 2019; 3 (02) 86-90
  CrossrefPubMedGoogle Scholar
• 6 Grünert SC, Schlatter SM, Schmitt RN. et al. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: clinical presentation and outcome in a series of 37 patients. Mol Genet Metab 2017; 121 (03) 206-215
  CrossrefPubMedGoogle Scholar
• 7 Conboy E, Vairo F, Schultz M. et al. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: unique presenting laboratory values and a review of biochemical and clinical features. JIMD Rep 2018; 40: 63-69
  CrossrefPubMedGoogle Scholar
• 8 Gibson KM, Breuer J, Kaiser K. et al. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: report of five new patients. J Inherit Metab Dis 1988; 11 (01) 76-87
  CrossrefPubMedGoogle Scholar
• 9 Mitchell GA, Gauthier N, Lesimple A, Wang SP, Mamer O, Qureshi I. Hereditary and acquired diseases of acyl-coenzyme A metabolism. Mol Genet Metab 2008; 94 (01) 4-15
  CrossrefPubMedGoogle Scholar
• 10 Aledo R, Mir C, Dalton RN. et al. Refining the diagnosis of mitochondrial HMG-CoA synthase deficiency. J Inherit Metab Dis 2006; 29 (01) 207-211
  CrossrefPubMedGoogle Scholar
• 11 Pitt JJ, Peters H, Boneh A. et al. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: urinary organic acid profiles and expanded spectrum of mutations. J Inherit Metab Dis 2015; 38 (03) 459-466
  CrossrefPubMedGoogle Scholar
• 12 Aoyama Y, Yamamoto T, Sakaguchi N. et al. Application of multiplex ligation-dependent probe amplification, and identification of a heterozygous Alu-associated deletion and a uniparental disomy of chromosome 1 in two patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Int J Mol Med 2015; 35 (06) 1554-1560
  CrossrefPubMedGoogle Scholar
• 13 Sass JO, Grünert SC. Disorders of ketone body metabolism. In: Blau N, Duran M, Gibson K, Dionisi Vici C. eds. Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Berlin, Heidelberg: Springer; 2014: 361-371
  Google Scholar